Home / Discover / Fund

Nippon India Nifty Pharma ETF

Nippon India Mutual Fund ETF Passive As of 2026-05-31
Compare Run analysis Research Academy
Holdings
21
Concentrated
Top 10 weight
78%
Concentration
Strategy
Index
Passive exposure
Equity
100%
Asset allocation

Portfolio

1Sectors 7Large positions 99.5%Top: Pharmaceuticals & Biotechnology 0.5%Cash

Market-cap allocation

Large cap54%
Mid cap37%
Small cap8%

Asset allocation

Equity100%

Top holdings

Sun Pharmaceutical Industries LimitedEQUITY
21.3%
Divi's Laboratories LimitedEQUITY
9.5%
Dr. Reddy's Laboratories LimitedEQUITY
8.9%
Cipla LimitedEQUITY
8.8%
Lupin LimitedEQUITY
6.2%
Laurus Labs LimitedEQUITY
5.9%
Torrent Pharmaceuticals LimitedEQUITY
5.2%
Aurobindo Pharma LimitedEQUITY
4.5%
Glenmark Pharmaceuticals LimitedEQUITY
3.8%
Alkem Laboratories LimitedEQUITY
3.6%

AI Smart summary

Portfolio read

  • 100% equity.
  • Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
  • Largest equity sector is Pharmaceuticals & Biotechnology at 99.5% of the portfolio.

Watchpoints

  • Compact 21-position portfolio; each large position can materially affect returns.
  • Top 10 positions account for 78%, indicating high portfolio concentration.
  • Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 100%.

Auto-generated from fund metrics. Educational only - not investment advice.

Peer comparison

Other funds in ETF.

Edelweiss NIFTY Largemidcap 250 ETF255 holdings · 22% top 10
SBI Nifty Small Cap 250 ETF251 holdings · 11% top 10
Zerodha NIFTY Midcap 150 ETF152 holdings · 19% top 10
SBI Nifty Midcap150 ETF151 holdings · 19% top 10
UTI Nifty Midcap 150 Exchange Traded Fund151 holdings · 19% top 10
Zerodha NIFTY 100 ETF106 holdings · 43% top 10

Sector exposure

Full industry / sector breakdown aggregated from the fund's holdings.

Pharmaceuticals & Biotechnology99.5%